{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:14:08Z","timestamp":1774289648205,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Experimental evidence points to the role of Zinc fingers and homeoboxes protein 1 and 2 (ZHX1 and ZHX2) in the development and progression of several types of cancer, including hematological malignancies. Here, we determined whether the altered expression of <jats:italic>ZHX1<\/jats:italic> and <jats:italic>ZHX2<\/jats:italic> has clinical implications in patients with CLL. Interestingly, CLL patients with low expression <jats:italic>ZHX1<\/jats:italic> and <jats:italic>ZHX2<\/jats:italic> presented higher WBC counts. Importantly, our data showed that CLL patients with cytogenetic alterations presented reduced transcriptional levels of <jats:italic>ZHX1<\/jats:italic> and <jats:italic>ZHX2<\/jats:italic> in comparison with patients with normal karyotype. Moreover, when stratifying CLL patients according to the karyotype prognosis value, we observed that the expression of <jats:italic>ZHX1<\/jats:italic> and <jats:italic>ZHX2<\/jats:italic> was significantly reduced in CLL patients presenting adverse karyotypes. Finally, we stratified patients according to the number of chromosomal aberrations and observed a negative association between <jats:italic>ZHX1<\/jats:italic> and <jats:italic>ZHX2<\/jats:italic> expression and the accumulation of chromosomal abnormalities in CLL patients. Our data showed that the low expression of <jats:italic>ZHX1<\/jats:italic> and <jats:italic>ZHX2<\/jats:italic> is associated with a worse prognosis in CLL, followed by a greater number of leukemic cells and unfavorable cytogenetics findings in the diagnosis. Further studies will be important to confirm the prognostic value of ZHX1 and ZHX2 in independent CLL cohorts.<\/jats:p>","DOI":"10.1186\/s40364-021-00263-2","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T17:19:03Z","timestamp":1612459143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia"],"prefix":"10.1186","volume":"9","author":[{"given":"Nat\u00e1lia Ioseph Gladistone","family":"Maciel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luma Dayane Carvalho","family":"Fili\u00fa-Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Assis Rocha","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Magalhaes","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Roberto","family":"Lucena-Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4200-0821","authenticated-orcid":false,"given":"Felipe","family":"Saldanha-Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"263_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cgt.2015.16","volume":"22","author":"Y Liu","year":"2015","unstructured":"Liu Y, Ma D, Ji C. Zinc fingers and homeoboxes family in human diseases. Cancer Gene Ther. 2015;22:223\u20136.","journal-title":"Cancer Gene Ther"},{"key":"263_CR2","doi-asserted-by":"publisher","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","volume":"44","author":"FO Bagger","year":"2016","unstructured":"Bagger FO, Sasivarevic D, Sohi SH, Laursen LG, Pundhir S, S\u00f8nderby CK, et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 2016;44:D917\u201324.","journal-title":"Nucleic Acids Res"},{"key":"263_CR3","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1182\/blood-2017-03-772285","volume":"129","author":"GM Rigolin","year":"2017","unstructured":"Rigolin GM, Cavallari M, Quaglia FM, Formigaro L, Lista E, Urso A, et al. In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI. Blood. 2017;129:3495\u20138.","journal-title":"Blood"},{"key":"263_CR4","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, Leupolt E, Kr\u00f6ber A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910\u20136.","journal-title":"N Engl J Med"},{"key":"263_CR5","doi-asserted-by":"publisher","unstructured":"Cohen JA, Bomben R, Pozzo F, Tissino E, H\u00e4rzschel A, Hartmann TN, et al. An updated perspective on current prognostic and predictive biomarkers in chronic lymphocytic leukemia in the context of chemoimmunotherapy and novel targeted therapy. Cancers. 2020;12. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.3390\/cancers12040894","DOI":"10.3390\/cancers12040894"},{"key":"263_CR6","doi-asserted-by":"publisher","first-page":"e0171036","DOI":"10.1371\/journal.pone.0171036","volume":"12","author":"R-J Kwon","year":"2017","unstructured":"Kwon R-J, Kim YH, Jeong DC, Han M-E, Kim J-Y, Liu L, et al. Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma. PLoS One. 2017;12:e0171036.","journal-title":"PLoS One"},{"key":"263_CR7","first-page":"6","volume":"7","author":"X Ma","year":"2016","unstructured":"Ma X, Huang M, Wang Z, Liu B, Zhu Z, Li C. ZHX1 inhibits gastric cancer cell growth through inducing cell-cycle arrest and apoptosis. J Cancer. 2016;7:6\u20138.","journal-title":"J Cancer"},{"key":"263_CR8","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1053\/j.gastro.2012.02.049","volume":"142","author":"X Yue","year":"2012","unstructured":"Yue X, Zhang Z, Liang X, Gao L, Zhang X, Zhao D, et al. Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E. Gastroenterology. 2012;142:1559\u201370.e2.","journal-title":"Gastroenterology"},{"key":"263_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2141.2007.06956.x","volume":"141","author":"A Armellini","year":"2008","unstructured":"Armellini A, Sarasquete ME, Garc\u00eda-Sanz R, Chill\u00f3n MC, Balanzategui A, Alcoceba M, et al. Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma. Br J Haematol. 2008;141:212\u20135.","journal-title":"Br J Haematol."},{"key":"263_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.leukres.2011.10.019","volume":"36","author":"S Nagel","year":"2012","unstructured":"Nagel S, Schneider B, Meyer C, Kaufmann M, Drexler HG, Macleod RAF. Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma. Leuk Res. 2012;36:646\u201355.","journal-title":"Leuk Res"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-021-00263-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40364-021-00263-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-021-00263-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T17:31:46Z","timestamp":1612459906000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-021-00263-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["263"],"URL":"https:\/\/doi.org\/10.1186\/s40364-021-00263-2","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the local Ethical Committee. Written informed consent was obtained from all subjects included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}